USPTO TTABVUE. Trademark Trial and Appeal Board Inquiry System

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

TTABVUE. Trademark Trial and Appeal Board Inquiry System

v2.5.0

Summary

Query: Party Name contains all words: MERCK KGAA
Number of results: 226+
Results are in reverse chronological order

Proceeding
Filing Date

Defendant(s),
Property(ies)

Plaintiff(s),
Property(ies)

91180106
10/17/2007

Merck & Co., Inc.
Mark: ANTEZA S#:77163715

Merck KGaA
Mark: SANZEZA S#:78467250 R#:3045234
Mark: SANZESA S#:78718388

91179804
10/01/2007

Agouron Pharmaceuticals, Inc.
Mark: XENTRIOR S#:78923682

Merck KGaA
Mark: XENTRAX S#:79001132 R#:3076830

92048050
08/30/2007

Morinaga Milk Industry Co., Ltd.
Mark: TRI BION S#:75451620 R#:2512976

Merck KGaA

78725817
08/29/2007

American Generic Laboratories LLC
Mark: METABOTHIN S#:78725817

Merck KGaA

79030915
08/27/2007

Merck KGaA
Mark: LIQUID CRYSTALS S#:79030915

Liquidmetal Technologies, Inc.

77163715
07/26/2007

Merck & Co., Inc.
Mark: ANTEZA S#:77163715

Bayer Schering Pharma Aktiengesellschaft
Merck KGaA

78882496
07/10/2007

Societe des Produits Nestle S.A.
Mark: MUSASHI S#:78882496

Merck KGaA

78811509
07/05/2007

NATIVIS, INC.
Mark: NATIVIS S#:78811509

Merck KGaA

91178143
07/02/2007

Maximum Human Performance, Inc.
Mark: BIOFOLIN S#:76661103

MERCK KGAA
Mark: METAFOLIN S#:75761680 R#:2526532
Mark: METAFOLIN S#:78364095 R#:3001087

78818067
05/30/2007

American Society for Therapeutic Radiolo gy and Oncology
Mark: TARGETING CANCER CARE S#:78818067

Hoffmann-La Roche Inc.
Merck KGaA

91177478
05/24/2007

TANGO ADVANCED NUTRITION, INC.
Mark: METAPHASE S#:78872262

MERCK KGAA
Mark: METAFOLIN S#:75761680 R#:2526532
Mark: METAFOLIN S#:78364095 R#:3001087

91177011
04/27/2007

BIOVIGILANT SYSTEMS, INC.
Mark: IMD-L S#:78827624
Mark: IMD S#:78827608
Mark: IMD-A S#:78827615

Merck KGaA

76654219
04/26/2007

Center for Practical Bioethics, Inc.
Mark: CARING CONVERSATIONS S#:76654219

Merck KGaA

78923682
04/26/2007

Agouron Pharmaceuticals, Inc.
Mark: XENTRIOR S#:78923682

Merck KGaA

78776815
04/10/2007

EMERGENCY MEDICAL TECHNOLOGIES, INC.
Mark: EMT S#:78776815

Merck KGaA

78929476
03/23/2007

Georgiou, George John
Mark: HMD S#:78929476

Merck KGaA

91176335
03/21/2007

Merck KGaA
Mark: TARGETING CANCER FOR BETTER LIVES S#:78899450

Dendreon Corporation

78765500
03/07/2007

Human Genome Sciences, Inc.
Mark: ADEPZAR S#:78765500

Merck KGaA

91176002
03/05/2007

Sud-Chemie AG
Mark: REFORMAX S#:78634324

Merck KGaA

91175883
02/07/2007

Bentoli, Inc.
Mark: SEMALEX S#:78710713

Merck KGaA

91175674
02/14/2007

Niavin Corporation
Mark: NIAVIN S#:78804999

Merck KGaA

76661103
02/01/2007

Maximum Human Performance, Inc.
Mark: BIOFOLIN S#:76661103

MERCK KGAA

78710713
12/29/2006

Bentoli, Inc.
Mark: SEMALEX S#:78710713

Merck KGaA

91174814
12/22/2006

Herbal Worldwide Holdings, LLC
Mark: METABOSIN S#:78776290

Merck KGaA

78899450
12/21/2006

Merck KGaA
Mark: TARGETING CANCER FOR BETTER LIVES S#:78899450

Dendreon Corporation